Permethrin-treated baby wraps for the prevention of malaria in children: Protocol for a double-blind, randomized placebo-controlled controlled trial in western Uganda.

This article details the study protocol for a double-blind, randomized placebo-controlled trial to determine the effectiveness of permethrin-treated baby wraps to prevent Plasmodium falciparum malaria infection in children 6-24 months of age. Participating mother-infant dyads will be randomized to r...

Full description

Bibliographic Details
Main Authors: Ross M Boyce, Caitlin Cassidy, Ronnie Ndizeye, Emma Baguma, Dana Giandomenico, Bonnie E Shook-Sa, Moses Ntaro, Raquel Reyes, Edgar M Mulogo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0284322
_version_ 1827948724838465536
author Ross M Boyce
Caitlin Cassidy
Ronnie Ndizeye
Emma Baguma
Dana Giandomenico
Bonnie E Shook-Sa
Moses Ntaro
Raquel Reyes
Edgar M Mulogo
author_facet Ross M Boyce
Caitlin Cassidy
Ronnie Ndizeye
Emma Baguma
Dana Giandomenico
Bonnie E Shook-Sa
Moses Ntaro
Raquel Reyes
Edgar M Mulogo
author_sort Ross M Boyce
collection DOAJ
description This article details the study protocol for a double-blind, randomized placebo-controlled trial to determine the effectiveness of permethrin-treated baby wraps to prevent Plasmodium falciparum malaria infection in children 6-24 months of age. Participating mother-infant dyads will be randomized to receive either a permethrin-treated or a sham-treated wrap, known locally as a "lesu." After a baseline home visit, during which time all participants will receive new long-lasting insecticidal nets, participants will attend scheduled clinic visits every two weeks for a period of 24 weeks. In the event of an acute febrile illness or other symptoms that may be consistent with malaria (e.g., poor feeding, headache, malaise), participants will be instructed to present to their respective study clinic for evaluation. The primary outcome of interest is the incidence of laboratory-confirmed, symptomatic malaria in participating children. Secondary outcomes of interest include: (1) change in children's hemoglobin levels; (2) change in children's growth parameters; (3) prevalence of asymptomatic parasitemia in children; (4) hospitalization for malaria in children; (5) change in the mother's hemoglobin level; and (6) clinical malaria in the mother. Analyses will be conducted using a modified intent-to-treat approach, with woman-infant dyads who attend one or more clinic visits analyzed according to the arm to which they were randomly assigned. This is the first use of an insecticide-treated baby wrap for prevention of malaria in children. The study began recruitment in June 2022 and is ongoing. ClinicalTrials.gov Identifier: NCT05391230, Registered 25 May 2022.
first_indexed 2024-04-09T12:59:29Z
format Article
id doaj.art-d4808b5ccfd64b3e99160128384f9ee3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-09T12:59:29Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d4808b5ccfd64b3e99160128384f9ee32023-05-13T05:31:26ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01184e028432210.1371/journal.pone.0284322Permethrin-treated baby wraps for the prevention of malaria in children: Protocol for a double-blind, randomized placebo-controlled controlled trial in western Uganda.Ross M BoyceCaitlin CassidyRonnie NdizeyeEmma BagumaDana GiandomenicoBonnie E Shook-SaMoses NtaroRaquel ReyesEdgar M MulogoThis article details the study protocol for a double-blind, randomized placebo-controlled trial to determine the effectiveness of permethrin-treated baby wraps to prevent Plasmodium falciparum malaria infection in children 6-24 months of age. Participating mother-infant dyads will be randomized to receive either a permethrin-treated or a sham-treated wrap, known locally as a "lesu." After a baseline home visit, during which time all participants will receive new long-lasting insecticidal nets, participants will attend scheduled clinic visits every two weeks for a period of 24 weeks. In the event of an acute febrile illness or other symptoms that may be consistent with malaria (e.g., poor feeding, headache, malaise), participants will be instructed to present to their respective study clinic for evaluation. The primary outcome of interest is the incidence of laboratory-confirmed, symptomatic malaria in participating children. Secondary outcomes of interest include: (1) change in children's hemoglobin levels; (2) change in children's growth parameters; (3) prevalence of asymptomatic parasitemia in children; (4) hospitalization for malaria in children; (5) change in the mother's hemoglobin level; and (6) clinical malaria in the mother. Analyses will be conducted using a modified intent-to-treat approach, with woman-infant dyads who attend one or more clinic visits analyzed according to the arm to which they were randomly assigned. This is the first use of an insecticide-treated baby wrap for prevention of malaria in children. The study began recruitment in June 2022 and is ongoing. ClinicalTrials.gov Identifier: NCT05391230, Registered 25 May 2022.https://doi.org/10.1371/journal.pone.0284322
spellingShingle Ross M Boyce
Caitlin Cassidy
Ronnie Ndizeye
Emma Baguma
Dana Giandomenico
Bonnie E Shook-Sa
Moses Ntaro
Raquel Reyes
Edgar M Mulogo
Permethrin-treated baby wraps for the prevention of malaria in children: Protocol for a double-blind, randomized placebo-controlled controlled trial in western Uganda.
PLoS ONE
title Permethrin-treated baby wraps for the prevention of malaria in children: Protocol for a double-blind, randomized placebo-controlled controlled trial in western Uganda.
title_full Permethrin-treated baby wraps for the prevention of malaria in children: Protocol for a double-blind, randomized placebo-controlled controlled trial in western Uganda.
title_fullStr Permethrin-treated baby wraps for the prevention of malaria in children: Protocol for a double-blind, randomized placebo-controlled controlled trial in western Uganda.
title_full_unstemmed Permethrin-treated baby wraps for the prevention of malaria in children: Protocol for a double-blind, randomized placebo-controlled controlled trial in western Uganda.
title_short Permethrin-treated baby wraps for the prevention of malaria in children: Protocol for a double-blind, randomized placebo-controlled controlled trial in western Uganda.
title_sort permethrin treated baby wraps for the prevention of malaria in children protocol for a double blind randomized placebo controlled controlled trial in western uganda
url https://doi.org/10.1371/journal.pone.0284322
work_keys_str_mv AT rossmboyce permethrintreatedbabywrapsforthepreventionofmalariainchildrenprotocolforadoubleblindrandomizedplacebocontrolledcontrolledtrialinwesternuganda
AT caitlincassidy permethrintreatedbabywrapsforthepreventionofmalariainchildrenprotocolforadoubleblindrandomizedplacebocontrolledcontrolledtrialinwesternuganda
AT ronniendizeye permethrintreatedbabywrapsforthepreventionofmalariainchildrenprotocolforadoubleblindrandomizedplacebocontrolledcontrolledtrialinwesternuganda
AT emmabaguma permethrintreatedbabywrapsforthepreventionofmalariainchildrenprotocolforadoubleblindrandomizedplacebocontrolledcontrolledtrialinwesternuganda
AT danagiandomenico permethrintreatedbabywrapsforthepreventionofmalariainchildrenprotocolforadoubleblindrandomizedplacebocontrolledcontrolledtrialinwesternuganda
AT bonnieeshooksa permethrintreatedbabywrapsforthepreventionofmalariainchildrenprotocolforadoubleblindrandomizedplacebocontrolledcontrolledtrialinwesternuganda
AT mosesntaro permethrintreatedbabywrapsforthepreventionofmalariainchildrenprotocolforadoubleblindrandomizedplacebocontrolledcontrolledtrialinwesternuganda
AT raquelreyes permethrintreatedbabywrapsforthepreventionofmalariainchildrenprotocolforadoubleblindrandomizedplacebocontrolledcontrolledtrialinwesternuganda
AT edgarmmulogo permethrintreatedbabywrapsforthepreventionofmalariainchildrenprotocolforadoubleblindrandomizedplacebocontrolledcontrolledtrialinwesternuganda